Illumina to pay $8B to reacquire cancer blood test maker Grail, with all eyes on 2021 – Fierce Biotech

Illumina

Written by Conor Hale

Illumina will put down a total of $8 billion to reacquire its former spinout Grail, which, after nearly five years on its own, is nearing completion of a simple blood test capable of detecting 50 different …

By Bingyi Zeng
Bingyi Zeng Profile Picture
Read more »

Smith & Nephew to pick up Integra’s orthopedics business for $240M – Fierce Biotech

Smith

Written by Conor Hale

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The $240 million cash deal would not only add product portfolios covering shoulder replacements as …

By Bingyi Zeng
Bingyi Zeng Profile Picture
Read more »

Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash – Bristol Myers Squibb

Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash - Bristol Myers Squibb

Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or $225.00 per share in cash. The transaction was unanimously approved by both …

By Bingyi Zeng
Bingyi Zeng Profile Picture
Read more »

How Organizations Can Build Analytics Agility – MIT Sloan

EG2-Bieda-1290×860-1

Written by Lori C. Bieda

In an era of constant change, companies’ data and analytics capabilities must rapidly adapt to ensure that the business survives, never mind competes. Organizations seek insights from their data to inform strategic priorities in real …

By Bingyi Zeng
Bingyi Zeng Profile Picture
Read more »

4 Types of Networking Emails—and How to Write Them – Vault

jan-baborak-o4ntgxwr5sc-unsplash

Written by David Solloway

The more time that passes after you meet people for the first time—either in person or virtually—the harder it is to remember them. This is why, when you’re job searching, it’s important to take notes after meeting …

By Bingyi Zeng
Bingyi Zeng Profile Picture
Read more »